Specific Inhibitor of Matrix Metalloproteinase Decreases Tumor Invasiveness After Radiofrequency Ablation in Liver Tumor Animal Model
ObjectiveTo determine whether the specific inhibitor of matrix metalloproteinase (MMP)—batimastat (BB-94)—could decrease the progression of liver tumor after radiofrequency ablation (RFA) and achieve better therapeutic efficacy in an animal model.MethodsIn vitro experiments, the proliferation of H22...
Main Authors: | An-Na Jiang, Jing-Tao Liu, Kun Zhao, Hao Wu, Song Wang, Kun Yan, Wei Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-11-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2020.561805/full |
Similar Items
-
Radiofrequency Ablation: A Minimally Invasive Approach in Kidney Tumor Management
by: Marek S. Salagierski, et al.
Published: (2010-11-01) -
Minimally Invasive Radiofrequency Ablation for Large Thyroid Toxic Adenoma
by: Belitova M., et al.
Published: (2019-10-01) -
Stereotactic Radiofrequency Ablation of Liver Tumors in Octogenarians
by: Peter Schullian, et al.
Published: (2019-09-01) -
Study of matrix metalloproteinases and their tissue inhibitor in patients with ovarian tumors
by: K. P. Lactionov, et al.
Published: (2014-07-01) -
After insufficient radiofrequency ablation, tumor-associated endothelial cells exhibit enhanced angiogenesis and promote invasiveness of residual hepatocellular carcinoma
by: Kong Jian, et al.
Published: (2012-11-01)